Search - tctmd.com

Displaying 521 - 540 of 568

Sort: Relevancy | Date

Presentation TCT 2012

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Presenter: Bryan Yan

October 23, 2012

Presentation TCT 2012

Complications of the Radial Approach: Frequency, Prevention, and Management

Presenter: Tejas Patel

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Radiation Injury: Prevention, Consequences, and Mitigation

Presenter: Stephen Balter

October 22, 2012

Presentation TCT 2012

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Presenter: Carlos Mena

October 22, 2012

Presentation TCT 2012

DES Thrombosis: Acute Evaluation and Management for Short-term Success and Late Prevention

Presenter: Huay Cheem Tan

October 22, 2012

Presentation

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Presenter: Greg C. Flaker

October 09, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

Presentation

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Presenter: B-K Kim

September 19, 2012

Presentation

Double Antiplatelet Therapy After DES Implantation

Presenter: I. Ferreira-Gonz?lez

September 19, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

Presentation ESC 2012

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Presenter: 205474|Benjamin Scirica

August 26, 2012

Presentation

Indirect Comparisons of New Oral Anticoagulant Drugs When Used for Stroke Prevention in A-fib

Presenter: GYH Lip

August 13, 2012

Presentation ACVS 2012

Which Antiplatelets to Use for PCI?

Presenter: Dev Pahlajani

August 04, 2012

Presentation ACVS 2012

Peri-Operative Medical Management of Patient with Recurrent Ischemia

Presenter: Ravi Kumar Aluri

August 03, 2012

Presentation

Meta-Analysis of Transcatheter Closure vs. Medical Therapy for PFO in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism

Presenter: 164856|Shikhar Agarwal;

July 16, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Presenter: 204599|MP Bonaca

June 22, 2012

Advertisement

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Complications of the Radial Approach: Frequency, Prevention, and Management

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Radiation Injury: Prevention, Consequences, and Mitigation

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

DES Thrombosis: Acute Evaluation and Management for Short-term Success and Late Prevention

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Double Antiplatelet Therapy After DES Implantation

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Indirect Comparisons of New Oral Anticoagulant Drugs When Used for Stroke Prevention in A-fib

Which Antiplatelets to Use for PCI?

Peri-Operative Medical Management of Patient with Recurrent Ischemia

Meta-Analysis of Transcatheter Closure vs. Medical Therapy for PFO in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content